Anti-CCL11 Recombinant Antibody (Bertilimumab)

CAT#: TAB-724

Recombinant human monoclonal antibody expressed in CHO binding to human CCL11. Bertilimumab is a human monoclonal antibody that binds to eotaxin-1, an important regulator of overall eosinophil function. It was to be used to treat severe allergic disorders.

Gene Expression
Figure 1 RNA cell line category: Cell line enriched (BJ hTERT+) Figure 1 RNA cell line category: Cell line enriched (BJ hTERT+)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG4 - kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in ELISA, Neut, IF, IP, FC, FuncS and most other immunological methods.
  • Trade name
  • cat-213
  • CAS
  • 375348-49-5
  • Generic Name
  • bertilimumab
  • Related Disease
  • Allergies, severe ocular

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • bertilimumab;cat-213;375348-49-5;CAT-213;CAT213;iCo-008;CAT-212;CCL11;chemokine (C-C motif) ligand 11;SCYA11, small inducible cytokine subfamily A (Cys Cys), member 11 (eotaxin);eotaxin;eotaxin 1;MGC22554;eotaxin-1;C-C motif chemokine 11;small-inducible c
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-724. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-724, RRID: AB_3111992)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Bertilimumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Bertilimumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Bertilimumab"

Afuco™ Anti-CCL11 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-724)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human CCL11. It is a human monoclonal antibody that binds to eotaxin-1, an important regulator of overall eosinophil function. It was to be used to treat severe allergic disorders.
DrugMonitor™ Anti-Bertilimumab Antibody (VS-1224-YC187)
Bertilimumab is a fully human anti-eotaxin monoclonal antibody, initially developed for treating allergic disorders, currently in pre-clinical development for Allergic Rhinitis treatment. The DrugMonitor™ Anti-Bertilimumab Antibody (VS-1224-YC187) is an anti-drug antibody (ADA) against Bertilimumab. This drug-based antibody is raised in mice immunized with the Bertilimumab. The anti-Bertilimumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Bertilimumab in samples.

See other products for "CCL11"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
DrMAB-1054 Recombinant Mouse Anti-Human CCL11 Antibody Fab Fragment ELISA Fab
CAT Product Name Application Type
MOB-1389MZ Mouse Anti-CCL11 Recombinant Antibody (clone nythil-FPU2) ELISA Mouse IgG1
CAT Product Name Application Type
NEUT-109CQ Rat Anti-CCL11 Recombinant Antibody (NEUT-109CQ) Block, ELISA Rat IgG1, κ
CAT Product Name Application Type
MOR-0501 Hi-Affi™ Rabbit Anti-CCL11 Recombinant Antibody (clone DS501AB) WB Rabbit IgG
CAT Product Name Application Type
AFC-TAB-724 Afuco™ Anti-CCL11 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-724) FC, IP, ELISA, Neut, FuncS ADCC enhanced antibody
CAT Product Name Application Type
VS-0425-FY73 Human Anti-CCL11 (clone Bertilimumab) scFv-Fc Chimera ELISA Human IgG4, scFv-Fc
CAT Product Name Application Type
VS-0525-XY1053 Anti-Mouse CCL11 Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare